Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Covid: 30 blood clot cases found in AstraZeneca recipients in the UK
Also: Seven UK recipients of Oxford jab reported dead after clotting (The Guardian)
______________________________________________________________________
Source: BBC
Covid: 30 blood clot cases found in AstraZeneca recipients in the UK
2 April 2021
The UK's medicines watchdog says it has found 30 cases of rare blood clots in people who have had the Oxford-AstraZeneca Covid vaccine.
The Medicines and Healthcare products Regulatory Agency (MHRA) says the risk of having this type of clot is "very small".
The UK cases were out of more than 18 million doses given as of 24 March.
Fears over clots have led nations such as the Netherlands, Germany, France and Canada to restrict the jab's use.
-snip-
The MHRA said it had received 22 reports of cerebral venous sinus thrombosis (CVST) - where a blood clot forms in the brain - and eight reports of "other thrombosis events with low platelets [the cells involved in clotting]" following use of the Oxford-AstraZeneca jab, out of a total of 18.1 million doses given up to and including 24 March.
The watchdog said the benefits of the Oxford-AstraZeneca vaccine in preventing Covid-19 infection and its complications continued to outweigh any risks, and urged the public to accept the jab when offered it.
-snip-
2 April 2021
The UK's medicines watchdog says it has found 30 cases of rare blood clots in people who have had the Oxford-AstraZeneca Covid vaccine.
The Medicines and Healthcare products Regulatory Agency (MHRA) says the risk of having this type of clot is "very small".
The UK cases were out of more than 18 million doses given as of 24 March.
Fears over clots have led nations such as the Netherlands, Germany, France and Canada to restrict the jab's use.
-snip-
The MHRA said it had received 22 reports of cerebral venous sinus thrombosis (CVST) - where a blood clot forms in the brain - and eight reports of "other thrombosis events with low platelets [the cells involved in clotting]" following use of the Oxford-AstraZeneca jab, out of a total of 18.1 million doses given up to and including 24 March.
The watchdog said the benefits of the Oxford-AstraZeneca vaccine in preventing Covid-19 infection and its complications continued to outweigh any risks, and urged the public to accept the jab when offered it.
-snip-
Read more: https://www.bbc.com/news/health-56616119
______________________________________________________________________
Source: The Guardian
Seven UK recipients of Oxford jab reported dead after clotting
Experts say numbers of rare blood clots remain low and benefits of Covid vaccine far outweigh risks
Nicola Davis Science correspondent
@NicolaKSDavis
Fri 2 Apr 2021 13.18 EDT
Further cases of a rare blood clotting syndrome including seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.
The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card” scheme to pick up suspected side-effects or other concerns for medicines and medical devices.
According to the latest figures from the MHRA, there have been 22 reports of a blood clot in the brain called cerebral venous sinus thrombosis (CVST) that was accompanied by a low platelet count as well as eight reports of other blood clotting problems with low platelets, among recipients of the Oxford/AstraZeneca jab up to and including 24 March. Platelets are fragments in the blood that help it to clot. Of these 30 reports, the MHRA told the Guardian seven people had died.
However, such cases remain rare: the MHRA notes that by 24 March, 18.1m doses of the Covid-19 Oxford vaccine had been given.
There have also been two cases of CVST among people who received the Pfizer/BioNTech jab, neither of them accompanied by a low platelet count.
-snip-
Experts say numbers of rare blood clots remain low and benefits of Covid vaccine far outweigh risks
Nicola Davis Science correspondent
@NicolaKSDavis
Fri 2 Apr 2021 13.18 EDT
Further cases of a rare blood clotting syndrome including seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.
The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card” scheme to pick up suspected side-effects or other concerns for medicines and medical devices.
According to the latest figures from the MHRA, there have been 22 reports of a blood clot in the brain called cerebral venous sinus thrombosis (CVST) that was accompanied by a low platelet count as well as eight reports of other blood clotting problems with low platelets, among recipients of the Oxford/AstraZeneca jab up to and including 24 March. Platelets are fragments in the blood that help it to clot. Of these 30 reports, the MHRA told the Guardian seven people had died.
However, such cases remain rare: the MHRA notes that by 24 March, 18.1m doses of the Covid-19 Oxford vaccine had been given.
There have also been two cases of CVST among people who received the Pfizer/BioNTech jab, neither of them accompanied by a low platelet count.
-snip-
Read more: https://www.theguardian.com/society/2021/apr/02/covid-further-rare-blood-clot-cases-found-in-oxford-astrazeneca-recipients
1 replies
= new reply since forum marked as read
= new reply since forum marked as read
